| 763998 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
893 ATG-101, a novel PD-L1/4–1BB bispecific antibody, augments anti-tumor immunity through immune checkpoint inhibition and PDL1-directed 4–1BB activation |
2021-11-01 |
10.1136/jitc-2021-sitc2021.893 |
Yuwen Hui, Li Tengteng, Ren Yijing, Hoenemann Dirk, Mei Jay, Shan Bo, Hou Bing |
| 763997 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
892 ABL503 (TJ-L14B), PD-L1x4–1BB bispecific antibody induces superior anti-tumor activity by PD-L1-dependent 4–1BB activation with the increase of 4–1BB+CD8+ T cells in tumor microenvironment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.892 |
Jung Uijung, Jeon Jaehyoung, Lee Shinai, Jin Hyung-Seung, Kim Youngkwang, Sung Eunsil, Kim Hyunjoo, Lim Yangmi, Won Jonghwa, Wang Zhengyi, Jiang Wenqing, Jung Jaeho, You Gihoon |
| 763996 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
891 S-531011, a novel anti-human CCR8 antibody: antibody screening and evaluation of biological profiles |
2021-11-01 |
10.1136/jitc-2021-sitc2021.891 |
Yoshikawa Mai, Nagira Yoji, Nagira Morio, Yoshida Tetsuya, Yoshida Shinpei, Soh Tetsuyoshi, Wada Hisashi, Ohkura Naganari, Takahashi Tatsuya |
| 763995 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
890 Manipulation of epithelial-to-mesenchymal transition reveals metastatic breast cancers support immune suppression via heme metabolism |
2021-11-01 |
10.1136/jitc-2021-sitc2021.890 |
Williams Michelle, Hafeez Sabrina, Christenson Jessica, Spoelstra Nicole, Slansky Jill, Richer Jennifer |
| 763994 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
574 Multiplex microscopy reveals unique spatiotemporal effects of cancer immunotherapies |
2021-11-01 |
10.1136/jitc-2021-sitc2021.574 |
Maltez Vivien, Byrne Katelyn, Germain Ronald |
| 763993 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
220 Transfection of human adipose-derived mast cells: a characteristic study using different chemical reagents |
2021-11-01 |
10.1136/jitc-2021-sitc2021.220 |
Motaghed Mona, Kepley Christopher, Dellinger Kristen, Fereydouni Mohammad, Ahani Elnaz |
| 763992 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
98 NX-0255, a small molecule CBL-B inhibitor, expands and enhances tumor infiltrating lymphocytes (TIL) for use in adoptive cancer immunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.098 |
Whelan Sarah, Gosling Jennifa, Mani Monisha, Cohen Frederick, Tenn-McClellan Austin, Powers Janine, Hansen Gwenn, Lotze Michael, Sands Arthur |
| 763991 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
172 Overcoming immunosuppressive TGF-β signaling in human ovarian cancer-derived tumor infiltrating lymphocytes via non-viral CRISPR engineering |
2021-11-01 |
10.1136/jitc-2021-sitc2021.172 |
Fix Samantha, Forget Marie-Andrée, Sakellariou-Thompson Donastas, Wang Yunfei, Dominguez Ana Lucía, Basar Rafet, Reyes Christopher, Kumar Sanjay, Meyer Larissa, Hwu Patrick, Bernatchez Chantale, Jazaeri Amir |
| 763990 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
152 Common trajectories of highly effective anti-CD19 chimeric antigen receptor-modified T cells identified by endogenous T cell receptor lineages |
2021-11-01 |
10.1136/jitc-2021-sitc2021.152 |
Wilson Taylor, Kim Hyunjin, Crawford Jeremy, Chou Ching-Heng, Langfitt Deanna, Kaitlynn Allen E, Lockey Timothy, Meagher Michael, Talleur Aimee, Gottschalk Stephen, Thomas Paul |
| 763989 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
197 Novel FcyR recombinant fusion facilitates antibody arming of engineered iPSC-derived NK cells to enhance targeting and killing of ovarian cancer cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.197 |
Snyder Kristin, Dixon Kate, Khaw Melissa, Davis Zachary, Rogers Paul, Hosking Martin, Bjordahl Ryan, Valamehr Bahram, Wu Jianming, Walcheck Bruce |
